The memantine market is estimated to be valued at US$ 565.93 Bn in 2022 and is expected to exhibit a CAGR of 3.87% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Memantine is a prescription drug used to treat moderate to severe Alzheimer's disease. It works by regulating levels of glutamate, an important chemical messenger in the brain that plays a ... Read more
Memantine is a prescription drug used to treat moderate to severe Alzheimer's disease. It is an NMDA receptor antagonist primarily used to manage neuropsychiatric symptoms in dementia patients. Memantine provides cognitive benefits for patients suffering from Alzheimer's and other dementias. It improves memory, thinking, language skills, understanding, and judgement in patients experiencing moderate to severe cognitive decline due to Alzheimer's disease.
